半胱氨酰白三烯受体拮抗剂孟鲁司特对糖尿病视网膜微血管内皮细胞自噬的抑制作用
本研究以20 ng/mL TNF-α和30 mM D-葡萄糖处理6至24小时的原代人视网膜微血管内皮细胞(HREC)为内皮活化模型,并以L-葡萄糖作为渗透压对照,评估CysLTR1信号及孟鲁司特的作用。结果显示高血糖与炎症诱导的CysLTR1表达升高触发自噬、IL-1β产生、连接完整性丧失、跨内皮电阻(TER)下降和白细胞迁移增加,孟鲁司特预处理可减轻上述效应且依赖CysLTR1。作者认为CysLTR1是治疗糖尿病黄斑水肿(DME)的潜在治疗靶点。
要点
- 高血糖与炎症使HREC的CysLTR1表达升高,2至6小时内触发自噬。
- 6至24小时内出现IL-1β产生、连接完整性丧失、TER下降及白细胞迁移增加。
- 孟鲁司特预处理可减轻上述改变,作用依赖CysLTR1。
核心结论
- 功能失调的视网膜内皮启动炎症、自噬与完整性受损的自我强化循环,并与CysLTR1水平升高相关。
- 孟鲁司特对CysLTR1的拮抗作用可有效减轻这些有害改变。
- 本研究提示CysLTR1是治疗DME的潜在治疗靶点,并提供减轻DR有害改变的新策略。
研究设计与样本
- 以20 ng/mL TNF-α和30 mM D-葡萄糖处理6至24小时的原代人视网膜微血管内皮细胞(HREC)作为内皮活化模型。
- HREC与L-葡萄糖孵育作为渗透压对照。
- 采用CysLTR1敲低和孟鲁司特预处理评估CysLTR1拮抗作用。
- 采用基因表达、蛋白表达和细胞通透性染料检测自噬与炎症。
- 测定跨内皮电阻(TER)和单核白细胞跨HREC单层的跨内皮迁移,作为血管通透性的功能评估。
主要发现
- 高血糖和炎症诱导的内皮活化使CysLTR1表达增加,并在2至6小时内触发自噬。
- 内皮活化在6至24小时内引起IL-1β产生、连接完整性丧失、TER下降和白细胞迁移增加。
- 孟鲁司特预处理有效减轻上述效应,显示其作用依赖CysLTR1。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diabetic macular edema (DME) is the primary cause of vision impairment in diabetic retinopathy (DR) patients. A previous study has shown the efficacy of montelukast, a cysteinyl leukotriene receptor (CysLTR)1 antagonist, in a diabetic mouse model. This study aims to understand the CysLTR1 signaling in retinal endothelial cells and the impact of montelukast. METHODS: Primary human retinal microvascular endothelial cells (HRECs) challenged with 20 ng/mL TNF-α and 30 mM D-glucose (D-glu) for six to 24 hours served as a model of endothelial activation. HRECs were incubated with L-glucose (L-glu) as an osmotic control. CysLTR1 knockdown and montelukast pretreatment assessed CysLTR1 antagonism. Gene expression, protein expression, and cell-permeable dyes were utilized to measure autophagy and inflammation. Transendothelial electrical resistance (TER) and transendothelial migration of mononuclear leukocytes across HRECs monolayer were measured as a functional assessment of vascular permeability. RESULTS: Endothelial activation induced by hyperglycemia and inflammation increased CysLTR1 expression, triggering autophagy within two to six hours, IL-1β production, loss of junction integrity, decreased TER, and increased leukocyte migration within six to 24 hours. Pretreatment with montelukast effectively alleviated these effects, demonstrating its dependence on CysLTR1. CONCLUSIONS: Dysfunctional retinal endothelium initiates a self-reinforcing loop of inflammation, autophagy, and compromised integrity associated with heightened CysLTR1 levels. The antagonistic effect of montelukast against CysLTR1 effectively mitigates these detrimental changes. This study reveals CysLTR1 as a potential therapeutic target in treating DME and offers a novel strategy to mitigate detrimental changes in DR.
引用
- Awad AM, Seetharaman ATM, Hossain MS, et al. Cysteine Leukotriene Receptor Antagonist-Montelukast Effects on Diabetic Retinal Microvascular Endothelial Cells Curtail Autophagy. Invest Ophthalmol Vis Sci. 2024. PMID: 39504050. doi:10.1167/iovs.65.13.15
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。